Osimertinib mesylate

active pharmaceutical ingredient

N-(2-((2-Acrylamido-5-methoxy-4-((4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl)amino)phenyl)(methyl)amino)ethyl)-3-((2-((2-(dimethylamino)ethyl)(methyl)amino)-4-methoxy-5-((4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl)amino)phenyl)amino)-N,N-dimethyl-3-oxopropan-1-aminium

research compound

4-CYANOBIPHENYL

Pharmaceutical intermediate synthesis

2'-Deoxyadenosine 5'-monophosphate sodium

pharmaceutical intermediate

DMTr-2'-O-C22-rU-3'-CE-Phosphoramidite

Modified uridine phosphoramidite for oligonucleotide synthesis

5'(E)-VP-2 inverted exclamation mark -F-U-CE-Phoshoramidite

Nucleotide phosphoramidite building block